Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Authors: Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Weily Soong, Mercedes E. González, Lynda C. Schneider, Robert Sidbury, Benjamin Lockshin, Steven M Meltzer, Zhixiao Wang, Leda Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P. Kosloski, Mohamed Kamal, Ariane Dubost-Brama, Naimish Patel, David M. Weinreich, George D. Yancopoulos, John T. O’Malley, Ashish Bansal, A. Pepper, Amy S. Paller, Benjamin Lockshin, David J. Cohen, David M. Pariser, Elaine C. Siegfried, Eric L. Simpson, Jeffrey Leflein, Jeffrey S. Weinberg, John Browning, Joyce Teng, Lara Wine Lee, Lawrence Sher, Lucia Z. Diaz, Lynda C. Schneider, Mercedes E. González, Ned T. Rupp, Peck Y. Ong, Robert Cartwright, Robert Sidbury, Weily Soong, Andreas Pinter, Andreas Wollenberg, Christina Schnopp, Michael J. Cork, Peter D. Arkwright, Anna Korkosz, Dorota Bystrzanowska, Ewa Sygula, Jacek Zdybski, Kamila Padlewska - The Lancet 2022 cited by 264